Stefania Ippati

850 total citations
20 papers, 399 citations indexed

About

Stefania Ippati is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Stefania Ippati has authored 20 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 9 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Stefania Ippati's work include Alzheimer's disease research and treatments (9 papers), Neuroscience and Neuropharmacology Research (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Stefania Ippati is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Neuroscience and Neuropharmacology Research (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Stefania Ippati collaborates with scholars based in Italy, Australia and United Kingdom. Stefania Ippati's co-authors include Mark Watling, Bruno P. Imbimbo, Claudia Balducci, Julia van der Hoven, Annika van Hummel, Lars M. Ittner, Yazi D. Ke, Mian Bi, André Bongers and Alexander Volkerling and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Stefania Ippati

20 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefania Ippati Italy 13 204 148 82 79 59 20 399
Lieven Declercq Belgium 9 157 0.8× 90 0.6× 84 1.0× 64 0.8× 63 1.1× 11 362
Sophie Robinson United Kingdom 7 180 0.9× 196 1.3× 77 0.9× 26 0.3× 111 1.9× 8 433
Shohreh Majd Australia 12 201 1.0× 205 1.4× 70 0.9× 46 0.6× 94 1.6× 19 438
Edgar Dawkins Australia 9 214 1.0× 174 1.2× 44 0.5× 121 1.5× 81 1.4× 10 428
Rudy Chang United States 9 173 0.8× 124 0.8× 151 1.8× 54 0.7× 32 0.5× 13 447
Kathleen Seyb United States 14 146 0.7× 214 1.4× 53 0.6× 67 0.8× 183 3.1× 19 546
Hideomi Hamasaki Japan 11 148 0.7× 192 1.3× 71 0.9× 103 1.3× 51 0.9× 30 402
Isabella Ogorek Germany 7 169 0.8× 124 0.8× 100 1.2× 44 0.6× 20 0.3× 10 357
Ala Litman‐Zawadzka Poland 8 201 1.0× 155 1.0× 65 0.8× 24 0.3× 52 0.9× 11 423
Surabhi Bhatia Australia 13 152 0.7× 217 1.5× 70 0.9× 67 0.8× 63 1.1× 16 447

Countries citing papers authored by Stefania Ippati

Since Specialization
Citations

This map shows the geographic impact of Stefania Ippati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Ippati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Ippati more than expected).

Fields of papers citing papers by Stefania Ippati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Ippati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Ippati. The network helps show where Stefania Ippati may publish in the future.

Co-authorship network of co-authors of Stefania Ippati

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Ippati. A scholar is included among the top collaborators of Stefania Ippati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Ippati. Stefania Ippati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Imbimbo, Bruno P., Claudia Balducci, Stefania Ippati, & Mark Watling. (2022). Initial failures of anti-tau antibodies in Alzheimer’s disease are reminiscent of the amyloid-β story. Neural Regeneration Research. 18(1). 117–117. 33 indexed citations
2.
Imbimbo, Bruno P., et al.. (2022). Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies. Pharmacological Research. 187. 106631–106631. 45 indexed citations
3.
Imbimbo, Bruno P., et al.. (2022). Should we lower or raise levels of amyloid-β in the brains of Alzheimer patients?. Pharmacological Research. 183. 106390–106390. 3 indexed citations
4.
Ippati, Stefania, Yuanyuan Deng, Julia van der Hoven, et al.. (2021). Rapid initiation of cell cycle reentry processes protects neurons from amyloid-β toxicity. Proceedings of the National Academy of Sciences. 118(12). 23 indexed citations
5.
Fumagalli, Stefano, Katarzyna Popiołek-Barczyk, Marina Sironi, et al.. (2021). Long pentraxin PTX3 is upregulated systemically and centrally after experimental neurotrauma, but its depletion leaves unaltered sensorimotor deficits or histopathology. Scientific Reports. 11(1). 9616–9616. 11 indexed citations
6.
Imbimbo, Bruno P., Stefania Ippati, Mark Watling, & Claudia Balducci. (2021). A critical appraisal of tau‐targeting therapies for primary and secondary tauopathies. Alzheimer s & Dementia. 18(5). 1008–1037. 45 indexed citations
7.
Deng, Yuanyuan, Annika van Hummel, Stefania Ippati, et al.. (2021). Syntaxins 6 and 8 facilitate tau into secretory pathways. Biochemical Journal. 478(7). 1471–1484. 6 indexed citations
8.
Imbimbo, Bruno P., Stefania Ippati, Mark Watling, & Claudia Balducci. (2021). Accelerating Alzheimer’s disease drug discovery and development: what’s the way forward?. Expert Opinion on Drug Discovery. 16(7). 727–735. 14 indexed citations
9.
Gregorc, Vanesa, Chiara Lazzari, Mario Mandalà, et al.. (2021). Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer. Cancers. 13(9). 2023–2023. 11 indexed citations
10.
Ciccone, Roselia, Antonio Vinciguerra, Stefania Ippati, et al.. (2021). Synthesis and Characterization of Novel Mono- and Bis-Guanyl Hydrazones as Potent and Selective ASIC1 Inhibitors Able to Reduce Brain Ischemic Insult. Journal of Medicinal Chemistry. 64(12). 8333–8353. 6 indexed citations
11.
Lazzari, Chiara, Aurora Mirabile, Alessandra Bulotta, et al.. (2021). History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature. Cancers. 13(5). 998–998. 7 indexed citations
12.
Fumagalli, Stefano, Nicholas J. Lynch, Silke Roscher, et al.. (2020). Targeted deletions of complement lectin pathway genes improve outcome in traumatic brain injury, with MASP-2 playing a major role. Acta Neuropathologica Communications. 8(1). 174–174. 14 indexed citations
13.
Imbimbo, Bruno P., Stefania Ippati, & Mark Watling. (2020). Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer’s disease or should they be looking elsewhere?. Expert Opinion on Drug Discovery. 15(11). 1241–1251. 15 indexed citations
14.
Imbimbo, Bruno P., et al.. (2020). Perspective: Is therapeutic plasma exchange a viable option for treating Alzheimer's disease?. Alzheimer s & Dementia Translational Research & Clinical Interventions. 6(1). e12004–e12004. 13 indexed citations
15.
Lazzari, Chiara, Alessandra Bulotta, Maria Giulia Cangi, et al.. (2020). Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities. Diagnostics. 10(12). 1092–1092. 19 indexed citations
16.
Hummel, Annika van, Julia van der Hoven, Marco Morsch, et al.. (2018). Selective Spatiotemporal Vulnerability of Central Nervous System Neurons to Pathologic TAR DNA-Binding Protein 43 in Aged Transgenic Mice. American Journal Of Pathology. 188(6). 1447–1456. 7 indexed citations
17.
Barca, Amilcare, Stefania Ippati, Emanuela Urso, et al.. (2018). Carnosine modulates the Sp1-Slc31a1/Ctr1 copper-sensing system and influences copper homeostasis in murine CNS-derived cells. American Journal of Physiology-Cell Physiology. 316(2). C235–C245. 25 indexed citations
18.
Barca, Amilcare, et al.. (2018). Responsiveness of Carnosine Homeostasis Genes in the Pancreas and Brain of Streptozotocin-Treated Mice Exposed to Dietary Carnosine. International Journal of Molecular Sciences. 19(6). 1713–1713. 14 indexed citations
19.
Hummel, Annika van, Mian Bi, Stefania Ippati, et al.. (2016). No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin Mice. PLoS ONE. 11(10). e0163236–e0163236. 29 indexed citations
20.
Ke, Yazi D., Annika van Hummel, Claire H. Stevens, et al.. (2015). Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS. Acta Neuropathologica. 130(5). 661–678. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lieven Declercq Breakdown of academic impact, for papers by Sophie Robinson Breakdown of academic impact, for papers by Shohreh Majd Breakdown of academic impact, for papers by Edgar Dawkins Breakdown of academic impact, for papers by Rudy Chang Breakdown of academic impact, for papers by Kathleen Seyb Breakdown of academic impact, for papers by Hideomi Hamasaki Breakdown of academic impact, for papers by Isabella Ogorek Breakdown of academic impact, for papers by Ala Litman‐Zawadzka Breakdown of academic impact, for papers by Surabhi Bhatia
Rankless by CCL
2026